{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:51:25Z","timestamp":1788565885405,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018610","name":"Innovation Program in Military Medicine of Chinese People\u2019s Liberation Army","doi-asserted-by":"publisher","award":["18CXZ031"],"award-info":[{"award-number":["18CXZ031"]}],"id":[{"id":"10.13039\/501100018610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014218","name":"Nanjing Military Region Medical Scientific and Technical Innovation Foundation Projects of Peoples Liberation Army of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770531"],"award-info":[{"award-number":["81770531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170575"],"award-info":[{"award-number":["82170575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clnesp.2023.11.008","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T23:14:18Z","timestamp":1701213258000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Predictive value of serum fibroblast growth factor 19 and liver stiffness for intestinal failure associated liver disease-cholestasis"],"prefix":"10.1016","volume":"59","author":[{"given":"Yaqin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulisudumu","family":"Maitiabula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niannian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshuai","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.clnesp.2023.11.008_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214480","article-title":"Parenteral nutrition overview","volume":"14","author":"Berlana","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2023.11.008_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2023.11.008_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.clnu.2012.05.004","article-title":"Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN","volume":"31","author":"Pironi","year":"2012","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2023.11.008_bib4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.clnu.2018.04.019","article-title":"Assessment of intestinal failure associated liver disease according to different diagnostic criteria","volume":"38","author":"Sasdelli","year":"2019","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2023.11.008_bib5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/apt.15432","article-title":"Review article: diagnosis and management of intestinal failure-associated liver disease in adults","volume":"50","author":"Bond","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clnesp.2023.11.008_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MPG.0000000000000586","article-title":"Intestinal failure-associated liver disease: a position paper of the ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation","volume":"60","author":"Lacaille","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2023.11.008_bib7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.31152","article-title":"New insights into intestinal failure-associated liver disease in children","volume":"71","author":"Khalaf","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clnesp.2023.11.008_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jpen.1524","article-title":"Systematic review: Noninvasive assessments of intestinal failure-associated liver disease in the adult population","volume":"43","author":"Huijbers","year":"2019","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2023.11.008_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072151","article-title":"Serum scoring and quantitative magnetic resonance imaging in intestinal failure-associated liver disease: a feasibility study","volume":"12","author":"Fragkos","year":"2020","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.clnesp.2023.11.008_bib10","article-title":"Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clnesp.2023.11.008_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Lund\u00e5sen","year":"2006","journal-title":"J\u00a0Intern Med"},{"issue":"10","key":"10.1016\/j.clnesp.2023.11.008_bib12","doi-asserted-by":"crossref","first-page":"G940","DOI":"10.1152\/ajpgi.00398.2012","article-title":"Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids","volume":"304","author":"Zhang","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"10.1016\/j.clnesp.2023.11.008_bib13","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clnesp.2023.11.008_bib14","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/ajcn\/nqz036","article-title":"Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)","volume":"109","author":"Koelfat","year":"2019","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2023.11.008_bib15","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/hep.22577","article-title":"Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis","volume":"48","author":"Millonig","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clnesp.2023.11.008_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2014.04.044","article-title":"Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan\u00ae","volume":"61","author":"Cassinotto","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"13","key":"10.1016\/j.clnesp.2023.11.008_bib17","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.cgh.2020.04.034","article-title":"Agreement between 2-dimensional shear wave and transient elastography values for diagnosis of advanced chronic liver disease","volume":"18","author":"Cassinotto","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnesp.2023.11.008_bib18","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clnu.2017.04.013","article-title":"Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey","volume":"37","author":"Pironi","year":"2018","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2023.11.008_bib19","first-page":"17","article-title":"[Evaluation of the effectiveness of ultrasound shear elastography and liver steatometry]","volume":"92","author":"Tarasova","year":"2020","journal-title":"Ter Arkh"},{"issue":"5","key":"10.1016\/j.clnesp.2023.11.008_bib20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ultrasmedbio.2015.03.009","article-title":"WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology","volume":"41","author":"Shiina","year":"2015","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"10.1016\/j.clnesp.2023.11.008_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2478\/pjs-2014-0021","article-title":"Cholelithiasis in home parenteral nutrition (Hpn) patients--complications of the clinical nutrition: diagnosis, treatment, prevention","volume":"86","author":"Lawi\u0144ski","year":"2014","journal-title":"Pol Przegl Chir"},{"issue":"5","key":"10.1016\/j.clnesp.2023.11.008_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archsurg.1996.01430170102020","article-title":"The role of prophylactic cholecystectomy in the short-bowel syndrome","volume":"131","author":"Thompson","year":"1996","journal-title":"Arch Surg"},{"issue":"7","key":"10.1016\/j.clnesp.2023.11.008_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2036.2008.03615.x","article-title":"Chronic biochemical cholestasis in patients receiving home parenteral nutrition: prevalence and predisposing factors","volume":"27","author":"Lloyd","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clnesp.2023.11.008_bib24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2015.03.012","article-title":"Intestinal failure to produce FGF19: a culprit in intestinal failure-associated liver disease?","volume":"62","author":"van Erpecum","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.clnesp.2023.11.008_bib25","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/hep.32017","article-title":"Chyme reinfusion restores the regulatory bile salt-FGF19 axis in patients with intestinal failure","volume":"74","author":"Koelfat","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clnesp.2023.11.008_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051376","article-title":"Chyme reinfusion in intestinal failure related to temporary double enterostomies and enteroatmospheric fistulas","volume":"12","author":"Picot","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2023.11.008_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clnu.2016.04.020","article-title":"Chyme reinfusion in patients with intestinal failure due to temporary double enterostomy: a 15-year prospective cohort in a referral centre","volume":"36","author":"Picot","year":"2017","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2023.11.008_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"247","key":"10.1016\/j.clnesp.2023.11.008_bib29","doi-asserted-by":"crossref","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","article-title":"A\u00a0nontumorigenic variant of FGF19 treats cholestatic liver diseases","volume":"6","author":"Luo","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723022076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723022076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:37:38Z","timestamp":1778881058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457723022076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":29,"alternative-id":["S2405457723022076"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.11.008","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of serum fibroblast growth factor 19 and liver stiffness for intestinal failure associated liver disease-cholestasis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}